Simultaneous knockdown or pharmacological inhibition of mTORC1 and LSD1 significantly enhanced primary cell differentiation and reduced the proportion of primary human AML cells (Deb et al., 2020). The gene discussed is KDM1A; the disease is acute myeloid leukemia.